Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nandrolone Decanoate for Sarcopenia
NCT05978206Phase 2Recruiting
- Start
- Aug 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nandrolone in Sarcopenia. Started Aug 2023; status: recruiting.
02
Drugs
nandrolone
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT05978206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05978206.